- Cannes film shocks with fairy-tale horror on abortion
- Schauffele equals major record low round with 62 to lead PGA
- Schauffele ties record-low major round with 62 for PGA lead
- Slovak PM speaking but serious after shooting, suspected gunman charged
- Ten Hag warns England's Shaw doubtful for Euro 2024
- Swiatek into Rome Open final as trophy record beckons, Paul battles through
- US bank regulator grilled over 'toxic culture' at agency
- Nigeria lawmaker's plan for mass wedding of orphans sparks uproar
- Ukraine trying to 'stabilise' front as Russia pushes northeast
- 'Fighter' Alaphilippe back winning in Giro 12th stage, Pogacar holds lead
- Demirtas: Erdogan's Kurdish nemesis condemned to prison
- Juve's Allegri suspended two matches after cup final red
- Hamilton says struggling Mercedes have found 'North Star'
- Trump lawyers vie to discredit key witness Cohen at trial
- England centre Slade signs new Exeter deal to end talk of France move
- Brazil's Porto Alegre: a flood disaster waiting to happen
- Resilient Schauffele grabs PGA lead as McIlroy's emotions tested
- 'I was trying to take a picture' with Slovak PM when he was shot: witness
- F1 design guru Newey will 'probably' join new team after Red Bull exit
- Walmart profits rise on strong sales from wealthier shoppers
- 100 years of British royal photography goes on display in London
- Alaphilippe wins Giro 12th stage, Pogacar holds race lead
- Nigerian women's rights pioneer celebrated in new biopic
- Israel vows to 'intensify' operations in Rafah
- Slovak PM 'able to speak' after shooting, suspected gunman charged
- Pyramids built along long-lost river, scientists discover
- London's Queen's Club to host WTA Tour event for first time in 52 years
- Paul survives chaotic ending to reach Rome Open semis
- French LGBTQ groups 'extremely concerned' over increase in attacks
- Anya Taylor-Joy praises 'unbelievable' 'Mad Max' stunt team
- Stocks waver after hitting record highs
- Green policies can be vote winners, London mayor says
- McIlroy shares early lead at emotionally testing PGA Championship
- S.Africa tells UN court Israel 'genocide' hit 'new and horrific stage'
- Man City's Ederson out of Premier League climax and FA Cup final
- 'Rappers and yodellers': Nagelsmann strikes balance in Euro 2024 squad
- England set to ban gender identity teaching in schools
- Serbia leases army HQ bombed by NATO to Trump son-in-law
- France deploys additional forces to quell New Caledonia unrest
- McIlroy faces emotional early test as PGA Championship begins
- Chelsea players 'love' Pochettino and must fight for him, says Palmer
- Germany boss Nagelsmann ignores Hummels to stick with regulars for Euros
- Sevilla great Navas to leave club in summer
- France accuses Azerbaijan of interference in New Caledonia riots
- European stocks dip from records, shrugging off gains elsewhere
- Toulouse's Chocobares eligible for Champions Cup final in spite of suspension
- Dutch EU opt-out on asylum could take 'years': Wilders to AFP
- Murray makes victorious comeback in Bordeaux
- China's Baidu posts weakest quarterly revenue growth in over a year
- EU probes Facebook, Instagram over child protection
RYCEF | -1.29% | 5.37 | $ | |
RBGPF | -1.42% | 59.7 | $ | |
NGG | 0.72% | 73.33 | $ | |
SCS | 0.48% | 13.675 | $ | |
CMSD | -0.3% | 24.3 | $ | |
RELX | -0.03% | 43.895 | $ | |
RIO | 1.66% | 71.52 | $ | |
VOD | 1.43% | 9.78 | $ | |
GSK | -0.97% | 44.89 | $ | |
BCC | -2.94% | 136.835 | $ | |
CMSC | -0.25% | 24.43 | $ | |
BCE | -0.76% | 34.31 | $ | |
JRI | -0.34% | 11.61 | $ | |
AZN | 0.17% | 77.1 | $ | |
BTI | 0.85% | 31.59 | $ | |
BP | -0.73% | 37.0535 | $ |
Philips settles US sleep machine cases for $1.1 billion
Dutch medical device maker Philips said Monday it had reached a $1.1 billion deal to settle US lawsuits over faulty sleep machines that have dogged the company.
The company's shares initially soared more than 45 percent in Amsterdam on news of the settlement, which was less onerous than feared by some shareholders, before ending the trading day up just over 28 percent.
Philips has been battling a series of crises since 2021 over its DreamStation machines for sleep apnoea, a disorder in which breathing intermittently stops during sleep.
Millions of devices were recalled over concerns that users were at risk of inhaling pieces of noise-cancelling foam and fears it could potentially cause cancer.
Earlier this year, the company decided to halt new sales in the United States of the machines made by subsidiary Philips Respironics.
Philips said in a statement Monday that it had reached an agreement with the plaintiffs "to resolve the personal injury litigation and the medical monitoring class action to end the uncertainty associated with litigation in the US."
It added that it did not "admit any fault or liability, or that any injuries were caused by Respironics' devices."
The agreement addresses claims filed in US courts and other potential cases, it said.
"Patient safety and quality is our highest priority, and we have taken important steps in further resolving the consequences of the Respironics recall," Philips chief executive Roy Jakobs said in the statement.
"The remediation of the sleep therapy devices for patients is almost complete, and the test results to date show the use of these devices is not expected to result in appreciable harm to health," he said.
"We do regret the concern that patients may have experienced," he said, adding that the settlements were "significant milestones and provide further clarity on the way forward for Philips."
Analysts at Jefferies investment firm said in a note that the settlement was "much milder than feared and shall mark the end of litigation uncertainty".
- 'We can move on' -
Philips, which has had to cut thousands of jobs, posted losses of 463 million euros ($501 million) over the full year in 2023.
It reported on Monday a loss of 824 million euros in the first quarter of this year on sales totalling 4.1 billion euros.
Philips said the settlement payments are expected to take place in 2025 and will be funded through cash flow generation.
The company said it had booked a provision of 982 million euros ($1.05 billion) in the first quarter to cover the settlement.
Philips said it also concluded an agreement with insurers to pay Philips 540 million euros to cover Respironics recall-related claims.
"The three biggest litigation cases that we had are now put behind us," Jakobs said in a conference call.
"We can move on and that's very important," he said, while cautioning that it "doesn't mean that everything is resolved."
Franco-German bank Oddo BHF said that "with the long tail of remaining legal risks being very manageable, we believe the settlement today materially derisks the investment case."
L.Dubois--BTB